Navigation Links
Ritter Pharmaceuticals Hires Dr. Howard Foyt as Executive Vice President, Development & Chief Medical Officer
Date:9/10/2009

LOS ANGELES, Sept. 10 /PRNewswire/ -- Ritter Pharmaceuticals, Inc. (Ritter) has hired Howard Foyt, M.D., Ph.D., FACP as its new Executive VP, Development & Chief Medical Officer. Dr. Foyt brings 13 years of expertise in drug development to Ritter, as the Company prepares to file an IND for its therapy for Lactose Intolerance.

Dr. Foyt will join Ritter's senior management team and oversee the Company's clinical development efforts. Ritter will take advantage of Dr. Foyt's leadership in drug development within big pharma and biotech companies. For the past three years, Dr. Foyt served as VP, Clinical Development and Chief Medical Officer at Metabasis Therapeutics, where he was responsible for five drugs in clinical development over multiple therapeutic areas. Dr. Foyt had previously worked at Pfizer, where he served as Senior Director and Site Head - Diabetes & Obesity, and earlier at Parke-Davis for over ten years participating in the clinical development of multiple drugs mainly in the metabolic disease field. Prior to joining Parke-Davis, Dr. Foyt was on the faculty at the University of Texas Medical Branch, Galveston, TX. He earned his medical degree and Ph.D. in Cell Biology from Baylor College of Medicine. Dr. Foyt completed his residency in internal medicine at Baylor and an endocrinology fellowship at the National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health.

"We are thrilled to have Dr. Foyt on our team," said Ritter Pharmaceuticals' President and CEO Andrew Ritter. "His breadth of clinical development and drug development experience will bring a great deal of scientific rigor and creativity to our development plans."

About Ritter Pharmaceuticals

Ritter is committed to the discovery, development and commercialization of innovative therapies for gastrointestinal diseases. The Company's scientific platform
'/>"/>

SOURCE Ritter Pharmaceuticals
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Reportlinker Adds US and European Radiopharmaceuticals Market Report
2. Cumberland Pharmaceuticals Launches Caldolor(R) in the United States for Treatment of Pain and Fever
3. Isis Pharmaceuticals to Present at Morgan Stanleys Global Healthcare Unplugged Conference
4. Rib-X Pharmaceuticals, Inc. Appoints Tom Kassberg Chief Business Officer
5. Jazz Pharmaceuticals to Present at Two Upcoming Investor Conferences
6. Anadys Pharmaceuticals to Present at Two Upcoming Investor Conferences
7. Amira Pharmaceuticals to Present at Thomas Weisel Partners Healthcare Conference
8. Steven Holtzman Joins Satori Pharmaceuticals Board of Directors
9. Endo Pharmaceuticals Introduces VALSTAR(TM) (Valrubicin) To Fill Unmet Need In Aggressive Form of Bladder Cancer
10. Peregrine Pharmaceuticals Reports Financial Results for the First Quarter of Fiscal Year 2010
11. Isis Pharmaceuticals to Present at Thomas Weisel Partners Healthcare Conference 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/25/2014)... 25, 2014 Triton Algae Innovations, ... announced Dr. Xun Wang has joined the ... Development. , Triton has developed a patented synthetic biology ... According to Dr. Wang, the platform uses algae to ... He says, “Algae are unique because they can produce ...
(Date:10/25/2014)... October 26, 2014 BioSkinLaser.Com, the leading ... most advanced and improved laser treatments for its customers. ... treatments like the lip enhancement treatment . It ... specific focus areas of each customer. , BioSkinLaser.Com has ... reduction NYC . The company cited that it created ...
(Date:10/25/2014)... New York, New York (PRWEB) October 25, 2014 ... lawsuits ( http://www.thexareltolawsuit.com/ ) will be addressed in December, ... convenes its next hearing session. According to a Hearing ... Oral Arguments on the matter will be heard on ... Session will begin at 9:30 a.m. (In Re: Xarelto ...
(Date:10/25/2014)... October 25, 2014 The global HCIT ... of 7.6%, to reach $50.4 billion by 2018 from ... systems industry, and pharmaceutical industry are driving the HCIT ... to enhance their focus on core business, reduce operational ... trained staff (further reducing hiring and training costs), share ...
(Date:10/25/2014)... Arriving home safe and sound is one of the best ... that costumes and goody bags have reflective strips that improve ... doctor at Meadowlands Hospital Medical Center in Secaucus, N.J. ... be flame-resistant, Davis said. He offers these others tips: ... on a small area of skin first to ensure it ...
Breaking Medicine News(10 mins):Health News:Triton Algae Innovations Ltd. Names Dr. Xun Wang as President 2Health News:Triton Algae Innovations Ltd. Names Dr. Xun Wang as President 3Health News:BioSkinLaser.Com Now Offers Advanced Medical Aesthetics Procedures 2Health News:BioSkinLaser.Com Now Offers Advanced Medical Aesthetics Procedures 3Health News:Xarelto Lawsuit News: JPML to Hear Oral Arguments on Proposed Xarelto Multidistrict Litigation at December Hearing, Bernstein Liebhard LLP Reports 2Health News:Xarelto Lawsuit News: JPML to Hear Oral Arguments on Proposed Xarelto Multidistrict Litigation at December Hearing, Bernstein Liebhard LLP Reports 3Health News:Global HCIT Outsourcing Market to Grow at 7.6% CAGR to 2018 Says a Premium Research Report Available at ReportsnReports.com 2Health News:Global HCIT Outsourcing Market to Grow at 7.6% CAGR to 2018 Says a Premium Research Report Available at ReportsnReports.com 3Health News:Global HCIT Outsourcing Market to Grow at 7.6% CAGR to 2018 Says a Premium Research Report Available at ReportsnReports.com 4Health News:Tips for Safe Trick-or-Treating 2
... New Orleans, LA, May 16 Two new ... the American Society of Hypertension (ASH) Twenty-Third Annual ... Orleans show that the milk-derived dietary supplement AmealPeptide ... studies, called AHEAD (Achieve Hypertension Efficacy with AmealPeptide ...
... An AIDS Vaccine is Possible and,Still Urgently Needed, ... of HIV, the world has made considerable advances in ... about HIV,perhaps more than any other pathogen, and have ... diseases combined. But this progress is not,enough. While it ...
... Less than a week after,committing medical relief efforts ... Project HOPE, an international health education and,humanitarian assistance ... to meet the urgent medical needs for the ... which has claimed over,20,000 lives., "I am ...
... based on abstracts or poster presentations at the annual ... to be held in Chicago, Illinois, May 30 ... Biomarker for Early Detection of Malignant Pleural Mesothelioma ... detection and prognostic marker,in malignant pleural mesothelioma, NYU Cancer ...
... are playing a major role in responding to ... ages who experience psychiatric and substance use,conditions each ... the,National Association of Psychiatric Health Systems (NAPHS) released ... two distinct views of behavioral,healthcare delivery. One chapter ...
... Senich, B.S.N., M.B.A.,M.P.H., Roche vice president, Sales and ... Jersey (EWNJ) at its "Salute to the Policy ... 15, 2008 at the Hyatt,Regency New Brunswick, recognized ... senior executives or members of boards of directors ...
Cached Medicine News:Health News:Calpis' AmealPeptide lowers blood pressure in 2 placebo-controlled trials 2Health News:World AIDS Vaccine Day 2008 2Health News:World AIDS Vaccine Day 2008 3Health News:World AIDS Vaccine Day 2008 4Health News:Project HOPE to Send Humanitarian Assistance to China as Humanitarian Assistance to Myanmar Continues 2Health News:NYU Langone Medical Center's tip sheet to the 44th annual meeting of ASCO 2Health News:NYU Langone Medical Center's tip sheet to the 44th annual meeting of ASCO 3Health News:NYU Langone Medical Center's tip sheet to the 44th annual meeting of ASCO 4Health News:New NAPHS Annual Survey Tracks Behavioral Treatment Trends 2Health News:Roche Vice President Senich Honored at EWNJ 'Salute to Policy Makers' 2Health News:Roche Vice President Senich Honored at EWNJ 'Salute to Policy Makers' 3
(Date:10/25/2014)... to a survey by KLAS, an independent research firm, ... the number one ranking in the medical and/or radiology ... report. The survey of 247 customers of various vendors ... take a commanding lead over their competitors." MOSAIQ scored ... they would buy again and 96 percent confirmed that ...
(Date:10/25/2014)... Research and Markets  has announced the ... Opportunities - Global Forecast to 2019" report to ... global dental equipment market is categorized on the basis ... market is expected to register the highest growth rate ... (2014 to 2019). This high growth is attributed to ...
(Date:10/25/2014)... 2014 Advanced Photonix ® (NYSE MKT: API) ... financial results on Monday, November 10, 2014. A press release ... of the market and the Company will host a live ... EDT on the same day. Participating in the ... Rob Risser (COO and Director), and Jeff ...
Breaking Medicine Technology:Elekta's MOSAIQ oncology information system ranks number one in KLAS Oncology 2014 report 2Elekta's MOSAIQ oncology information system ranks number one in KLAS Oncology 2014 report 3Dental Equipment Market Current Trends, Opportunities - Global Forecast to 2019 2Dental Equipment Market Current Trends, Opportunities - Global Forecast to 2019 3Advanced Photonix to Webcast Fiscal 2015 Second Quarter Earnings 2
... 26, 2011 Hamilton Company has been awarded a ... announced today. Hamilton Company, the Reno, NV-based global leader in ... investment in the manufacturing facility of its Swiss subsidiary Hamilton ... Named after Swiss national hero Wilhelm Tell, the Awards are ...
... The World Intellectual Property Organization (WIPO), in an ... Ventures for Global Health (BVGH), launched today ... and private sector organizations share valuable intellectual property ... community to promote development of new drugs, vaccines, ...
Cached Medicine Technology:Hamilton Company Wins Switzerland's 2010 Tell Award for Manufacturing Investment in Grisons, Greater Zurich Area 2Hamilton Company Wins Switzerland's 2010 Tell Award for Manufacturing Investment in Grisons, Greater Zurich Area 3Leading Pharmaceutical Companies & Research Institutions Offer IP and Expertise for Use in Treating Neglected Tropical Diseases as Part of WIPO Re:Search 2Leading Pharmaceutical Companies & Research Institutions Offer IP and Expertise for Use in Treating Neglected Tropical Diseases as Part of WIPO Re:Search 3Leading Pharmaceutical Companies & Research Institutions Offer IP and Expertise for Use in Treating Neglected Tropical Diseases as Part of WIPO Re:Search 4Leading Pharmaceutical Companies & Research Institutions Offer IP and Expertise for Use in Treating Neglected Tropical Diseases as Part of WIPO Re:Search 5Leading Pharmaceutical Companies & Research Institutions Offer IP and Expertise for Use in Treating Neglected Tropical Diseases as Part of WIPO Re:Search 6Leading Pharmaceutical Companies & Research Institutions Offer IP and Expertise for Use in Treating Neglected Tropical Diseases as Part of WIPO Re:Search 7
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: